IL18 and Parkinson disease: Thus, the inflammasome signaling proteins and inflammasome-associated pro-inflammatory cytokine IL-18 have demonstrated great reliability in distinguishing the inflammatory response in patients with PD when compared to age-matched, unaffected controls.